Latest News

Clinical trial | Image credit: photon_photo - stock.adobe.com
BioRationality: Efficacy Testing and Interchangeability of Biosimilar Remains a Dogma for Most

December 4th 2023

Sarfaraz K. Niazi, PhD, comments on a poll he conducted revealing that many are still hesitant to remove clinical efficacy study requirements for biosimilars in his latest column.

doctor supporting patient
Study Documents HCPs’ Experiences of a Mandatory Switch to Inform Future Transitions

December 2nd 2023

HHS on a phone | Image credit: Timon - stock.adobe.com
HHS Praises Biosimilars Savings but Opportunities to Reduce Part B Spending Remain

November 28th 2023

Image credit: Aliaksandr Marko | stock.adobe.com
Confusion Persists Around the Interchangeability Designation for Biosimilars

November 23rd 2023

injectable pens
BioRationality: FDA Publishes Results of First Meta-Analysis to Conclude All Biosimilars Are Interchangeable

November 20th 2023

More News

© 2023 MJH Life Sciences

All rights reserved.